Shares in Illumina Down 10.33 Percent After Analyst Downgrades Stock | GenomeWeb

NEW YORK, Feb. 10 (GenomeWeb News) - Shares in Illumina were down 10.33 percent, or $1.11, at $9.64 in late-afternoon trading after an investment bank downgraded the stock yesterday.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.